0001656472-20-000086.txt : 20200916 0001656472-20-000086.hdr.sgml : 20200916 20200916184501 ACCESSION NUMBER: 0001656472-20-000086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200915 FILED AS OF DATE: 20200916 DATE AS OF CHANGE: 20200916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN CENTRAL INDEX KEY: 0001797199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 201179707 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2G9 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wf-form4_160029628806998.xml FORM 4 X0306 4 2020-09-15 0 0001656472 Cronos Group Inc. CRON 0001797199 GORENSTEIN MICHAEL RYAN 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2G9 ONTARIO, CANADA 1 1 0 0 Executive Chairman COMMON SHARES 2020-09-15 4 M 0 645555 0.2353 A 1935005 D COMMON SHARES 2020-09-15 4 F 0 28108 5.40 D 1906897 D WARRANTS 0.2353 2020-09-15 4 M 0 645555 0 D COMMON SHARES 645555.0 0 D The price reported was converted from the Canadian exercise price of C$0.31 to U.S. dollars using an exchange rate of C$1.00 to US$0.7591 as reported by Bloomberg as of September 14, 2020. On September 15, 2020, the reporting person exercised warrants to purchase 645,555 common shares of Cronos Group Inc. (the "Company") for C$0.31 per common share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 28,108 common shares to pay the exercise price and issuing to the reporting person the remaining 617,447 common shares. The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.7591 as reported by Bloomberg as of September 14, 2020. 494,912 warrants were issued on October 8, 2015 and were immediately exercisable and expire on October 8, 2020. 150,643 warrants were issued on October 28, 2015 and were immediately exercisable and expire on October 28, 2020. Exhibit List: Exhibit 24 - Power of Attorney /s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein 2020-09-16 EX-24 2 a200914gorensteincronossec.htm POA

Michael Ryan Gorenstein  Exhibit 24


Authorization and Designation
to Sign and File
Section 16 Reporting Forms



    The undersigned, an executive officer and director of Cronos Group Inc., a
corporation incorporated under the British Columbia Business Corporations Act (the
"Company"), does hereby authorize and designate Jerry Barbato, Xiu Ming Shum or
Eileen Uy, each with right to substitute and resubstitute, but for only so long as each of
them is an officer of the Company, to sign and file on his or her behalf the application for
the required Securities and Exchange Commission ("SEC") electronic CIK/CCC codes
and any and all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the
Company with the SEC pursuant to the requirements of Section 16 of the Securities
Exchange Act of 1934 ("Section 16") and Rule 144 under the Securities Act of 1933, as
amended.  This authorization, unless earlier revoked in writing, shall be valid until the
undersigned's reporting obligations under Section 16 and Rule 144 with respect to equity
securities of the Company shall cease.  All prior such authorizations are hereby revoked.

    IN WITNESS WHEREOF, the undersigned has executed this Authorization and
Designation this 14th day of September, 2020.




                            /s/ Michael Ryan Gorenstein
                            Michael Ryan Gorenstein